Experts call out the need for affordable breast cancer treatment during the launch of trastuzumab biosimilar in the Philippines

In response to the prevailing threat of breast cancer in the Philippines, Pfizer has introduced a trastuzumab biosimilar to enable more Filipinos to have access to a more affordable treatment for HER2 positive breast cancer.

Announced during a recently held Oncology Summit organized by Pfizer and held at Grand Hyatt Manila, Taguig Philippines that was attended by leading healthcare practitioners and Oncology experts, Pfizer’s biosimilar Trastuzumab received the approval of the PhilippinesFood and Drug Administration (FDA) in March 2022 to bring this innovative treatment option to the Filipino patients. Trastuzumab refers to a monoclonal antibody that is used to treat specifictypes of HER2 positive breast cancers and stomach cancers.

Pfzier Ranked As Leading Company In Asia For COVID-19 Response And Patient-Centric Approach By Asian Patient Groups

Pfizer is ranked 1st in Australia/New Zealand region and overall 2nd in Asia in its corporate reputation from a patient perspective

Asian patient groups have placed the pharma industry 1st for corporate reputation in Asia amongst other healthcare sectors

Pfizer had been ranked first in its Covid-19 response, patient centricity, patient safety and bringing innovative, high-quality products amongst pharma companies in Asia in the ‘Corporate Reputation of Pharma’ survey by patient groups across the APAC region. Overall, the company is ranked second for its corporate reputation across Asian countries.

Pfizer moved up in the survey rankings from 4th place to occupy the top ranking in terms of patient groups ‘Working’ with Pfizer, representing a significant increase in rankings in 2021 vs. 2020, in ten Asian countries.

Pfizer partners with multiple organizations to deliver medicines and vaccines to isolated Mindanao community in Philippines via automated drone delivery

WeRobotics, Philippine Flying Labs, Pfizer, and local health workers of Agusan del Sur perform operations setup for the cargo delivery.

Pharmaceutical company Pfizer partnered with a number of agencies and organizations to launch a project that would see crucial medicines and vaccines easily delivered by drone to an isolated rural Mindanao community in the town of San Luis, Agusan del Sur.

The partnership also includes Geneva-based nonprofit drone organization WeRobotics, innovation solutions company Philippine Flying Labs, and the provincial government of Agusan del Sur in Mindanao.

Pfizer Philippines Foundation helps tackle the global health crisis with the Health Impact Hackathon

With the global COVID-19 pandemic currently causing massive amounts of stress on the world’s public health system, Pfizer Philippines Foundation, Inc. (PPFI), the corporate social responsibility arm of Pfizer Philippines, helped the country’s creative minds find a solution by partnering with Impact Hub Manila to host the Health vertical of the Impact Hackathon 2021, held virtually last August 26 to 28.

One of the hackathon’s main challenges was finding a way to provide crucial health information to communities who have limited to no access to the internet, especially during the pandemic.

Team Tesla won first place with CamMD, a desktop app that works as a first aid partner at home by identifying injuries or visible symptoms and uses object detection from different open-source libraries to determine the proper treatment. Team Hakushin Impact won first runner-up with Vacchain, an idea to use blockchain technology to digitize the country’s vaccination records and decentralize it in a comprehensive infrastructure, while Team Zenin Tech came in at second runner-up with Medic Marie, a personalized virtual health assistant that offers SMS-based healthcare services for rural communities.